HomeNDC LookupRxCUI directory › RxCUI 646456

Nystatin 100 UNT/MG Topical Powder — RxCUI 646456

RxNorm drug concept · Semantic clinical drug
RxCUI 646456 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 38 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI646456
Official nameNystatin 100 UNT/MG Topical Powder
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnystatin 100,000 UNT/GM Topical Powder
FDA products mapped16
Package NDCs mapped38
Reported Medicaid activity (SDUD)492,272 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nystatin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nystatin topical treats fungal skin infections caused by Candida — the same group of fungi responsible for yeast infections. These infections can appear in warm, moist areas of the...
  • What kind of infection does nystatin cream or powder actually treat?
  • For Candida foot infections, dust Nyamyc powder directly on your feet — and don't forget to also dust it inside your shoes and socks. For other skin areas, apply the powder to the...
  • How do I use the powder correctly, especially for a foot infection?
📖 Read our full Nystatin Topical guide →

🕸️ Concept Web — How Nystatin 100 UNT/MG Topical Powder Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nystatin 100 UNT/MG Topical Powder RxCUI 646456

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nystatin 7597
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nyamyc 584411
    • Nystop 218830
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nystatin Topical Powder 244416
    • Nystatin Topical Product 1160437
    • Nystatin Topical Powder [Nyamyc] 584413
    • Nystatin Topical Powder [Nystop] 367503
    • Nyamyc Topical Product 1179860
    • Nystop Topical Product 1179889
    • Topical Powder 317009
    • Topical Product 1151122
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nystatin 100 UNT/MG SCDC · 646455
  • Nystatin Topical Powder SCDF · 244416
  • Nystatin Topical Product SCDG · 1160437

Brand-Name Concepts

📦 FDA Products & Package NDCs

16 products · 38 package NDCs
38 package NDCs map to RxCUI 646456 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00574-2008-02 60 g in 1 BOTTLE, PLASTIC (0574-2008-02) Nystop Padagis US LLC 1996-08-16
00574-2008-15 15 g in 1 BOTTLE, PLASTIC (0574-2008-15) Nystop Padagis US LLC 1996-08-16
00574-2008-30 30 g in 1 BOTTLE, PLASTIC (0574-2008-30) Nystop Padagis US LLC 1996-08-16
00832-0465-15 1 BOTTLE, PLASTIC in 1 CARTON (0832-0465-15) / 15 g in 1 BO... Nyamyc Upsher-Smith Laboratories, LLC 2005-05-03
00832-0465-30 1 BOTTLE, PLASTIC in 1 CARTON (0832-0465-30) / 30 g in 1 BO... Nyamyc Upsher-Smith Laboratories, LLC 2005-05-03
00832-0465-60 1 BOTTLE, PLASTIC in 1 CARTON (0832-0465-60) / 60 g in 1 BO... Nyamyc Upsher-Smith Laboratories, LLC 2012-03-09
42806-0178-15 15 g in 1 BOTTLE (42806-178-15) Nystatin Topical Powder Epic Pharma, LLC 2018-05-02
42806-0178-30 30 g in 1 BOTTLE (42806-178-30) Nystatin Topical Powder Epic Pharma, LLC 2018-05-02
42806-0178-60 60 g in 1 BOTTLE (42806-178-60) Nystatin Topical Powder Epic Pharma, LLC 2018-05-02
42806-0185-15 15 g in 1 BOTTLE (42806-185-15) Nystatin Topical Powder Epic Pharma, LLC 2023-04-14
42806-0185-30 30 g in 1 BOTTLE (42806-185-30) Nystatin Topical Powder Epic Pharma, LLC 2023-04-14
42806-0185-60 60 g in 1 BOTTLE (42806-185-60) Nystatin Topical Powder Epic Pharma, LLC 2023-04-14
42806-0186-15 15 g in 1 BOTTLE (42806-186-15) KLAYESTA Epic Pharma, LLC 2023-04-14
42806-0186-30 30 g in 1 BOTTLE (42806-186-30) KLAYESTA Epic Pharma, LLC 2023-04-14
42806-0186-60 60 g in 1 BOTTLE (42806-186-60) KLAYESTA Epic Pharma, LLC 2023-04-14
63629-8696-01 15 g in 1 BOTTLE, PLASTIC (63629-8696-1) Nystop Bryant Ranch Prepack 1996-08-16
63629-8697-01 30 g in 1 BOTTLE, PLASTIC (63629-8697-1) Nystop Bryant Ranch Prepack 1996-08-16
63629-8698-01 60 g in 1 BOTTLE, PLASTIC (63629-8698-1) Nystop Bryant Ranch Prepack 1996-08-16
68382-0370-01 15 g in 1 BOTTLE, PLASTIC (68382-370-01) NYSTATIN Zydus Pharmaceuticals USA Inc. 2021-10-06
68382-0370-02 30 g in 1 BOTTLE, PLASTIC (68382-370-02) NYSTATIN Zydus Pharmaceuticals USA Inc. 2021-10-06
68382-0370-03 60 g in 1 BOTTLE, PLASTIC (68382-370-03) NYSTATIN Zydus Pharmaceuticals USA Inc. 2021-10-06
69315-0306-15 15 g in 1 BOTTLE, PLASTIC (69315-306-15) NYSTATIN Leading Pharma, LLC 2018-04-23
69315-0306-30 30 g in 1 BOTTLE, PLASTIC (69315-306-30) NYSTATIN Leading Pharma, LLC 2018-04-23
69315-0306-60 60 g in 1 BOTTLE, PLASTIC (69315-306-60) NYSTATIN Leading Pharma, LLC 2018-04-23
70771-1585-01 15 g in 1 BOTTLE, PLASTIC (70771-1585-1) NYSTATIN Zydus Lifesciences Limited 2021-10-06
70771-1585-02 30 g in 1 BOTTLE, PLASTIC (70771-1585-2) NYSTATIN Zydus Lifesciences Limited 2021-10-06
70771-1585-03 60 g in 1 BOTTLE, PLASTIC (70771-1585-3) NYSTATIN Zydus Lifesciences Limited 2021-10-06
71335-2845-01 15 g in 1 BOTTLE, PLASTIC (71335-2845-1) Nystop Bryant Ranch Prepack 2025-10-21
71335-2869-01 30 g in 1 BOTTLE, PLASTIC (71335-2869-1) Nystop Bryant Ranch Prepack 2025-10-21
72162-1124-02 15 g in 1 BOTTLE, PLASTIC (72162-1124-2) Nystop Bryant Ranch Prepack 2024-12-24
72162-1124-03 30 g in 1 BOTTLE, PLASTIC (72162-1124-3) Nystop Bryant Ranch Prepack 2024-12-24
72162-1124-06 60 g in 1 BOTTLE, PLASTIC (72162-1124-6) Nystop Bryant Ranch Prepack 2024-12-24
72603-0491-01 15 g in 1 BOTTLE, PLASTIC (72603-491-01) Nystatin Northstar Rx LLC 2025-09-01
72603-0491-02 30 g in 1 BOTTLE, PLASTIC (72603-491-02) Nystatin Northstar Rx LLC 2025-09-01
72603-0491-03 60 g in 1 BOTTLE, PLASTIC (72603-491-03) Nystatin Northstar Rx LLC 2025-09-01
75907-0060-30 30 g in 1 BOTTLE, PLASTIC (75907-060-30) Nystatin Dr. Reddy's Labratories Inc. 2024-05-28
75907-0060-44 15 g in 1 BOTTLE, PLASTIC (75907-060-44) Nystatin Dr. Reddy's Labratories Inc. 2024-05-28
75907-0060-60 60 g in 1 BOTTLE, PLASTIC (75907-060-60) Nystatin Dr. Reddy's Labratories Inc. 2024-05-28
Observed labelers: Epic Pharma, LLC (9) · Bryant Ranch Prepack (8) · Dr. Reddy's Labratories Inc. (3) · Leading Pharma, LLC (3) · Northstar Rx LLC (3) · Padagis US LLC (3) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.